Spectropathology for the next generation: Quo vadis?

Byrne, HJ; Baranska, M; Puppels, GJ; Stone, N; Wood, B; Gough, KM; Lasch, P; Heraud, P; Sule-Suso, J; Sockalingum, GD

doi:10.1039/C4AN02036G

Spectropathology for the next generation: Quo vadis?

Byrne, HJ; Baranska, M; Puppels, GJ; Stone, N; Wood, B; Gough, KM; Lasch, P; Heraud, P; Sule-Suso, J; Sockalingum, GD

Authors

HJ Byrne

M Baranska

GJ Puppels

N Stone

B Wood

KM Gough

P Lasch

P Heraud

Josep Sule-Suso j.sule-suso@keele.ac.uk

GD Sockalingum

Abstract

Although the potential of vibrational spectroscopy for biomedical applications has been well demonstrated, translation into clinical practice has been relatively slow. This Editorial assesses the challenges facing the field and the potential way forward. While many technological challenges have been addressed to date, considerable effort is still required to gain acceptance of the techniques among the medical community, standardise protocols, extend to a clinically relevant scale, and ultimately assess the health economics underlying clinical deployment. National and international research networks can contribute much to technology development and standardisation. Ultimately, large-scale funding is required to engage in clinical trials and instrument development.

Publication Date	Jan 1, 2015
Journal	Analyst
Print ISSN	0003-2654
Publisher	Royal Society of Chemistry
Pages	2066-2073
DOI	https://doi.org/10.1039/C4AN02036G
Publisher URL	https://doi.org/10.1039/c4an02036g